Warner Chilcott US LLC FDA Inspection Record
Warner Chilcott US LLC is an FDA-inspected facility (FEI 3000718423) located in Rockaway, NJ, US. RegDataLab tracks 1 FDA inspection at this facility.
What FDA found at this site
- Latest inspection
- Mar 16, 2012: No Action Indicated (NAI)
- Inspections on record
- 1 (1 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 9, latest May 17, 2013
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Mar 16, 2012 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| May 17, 2013 | Class II | D-822-2013 | Enablex (darifenacin) Extended Release Tablet, 15 mg per tablet. Physician Sample 7… Failed Impurities/Degradation Specifications: unspecified degradation product |
| Jul 7, 2011 | Class III | D-863-2012 | Ovcon 50 (Norethindrone and Ethinyl Estradiol, Tablets, USP) (trade 3 x 28''s); NDC… Subpotent; 12 month time point for ethinyl estradiol |
| Jun 21, 2011 | Class III | D-851-2012 | Femtrace (estradiol acetate) tablets, 1.8 mg, 100-count tablets per bottle, Rx only… Failed USP Dissolution Test Requirements: The recalled lot failed dissolution at the 9-month timepoint. |
| Sep 23, 2008 | Class III | D-199-2009 | femhrt 1 mg/5mcg (norethindrone acetate/ethinyl estradiol tablets), 1 mg/5 mcg, Rx only… Stability failure for ethinyl estradiol assay value at the 12 month time point for Lot 01167F. |
| Jun 23, 2008 | Class II | D-353-2008 | Mandelamine Hafgrams (Methenamine Mandelate Tablets), 0.5 gram, film coated, Rx only, 100… and 6 more products cGMP Deviations; Lack of stability indicating test methods |
| Sep 8, 2004 | Class II | D-067-5 | Estrace (estradiol tablets, USP) 1 mg tablets. 100 trade package. Manufactured by Bristol… Mislabeling: Outer carton incorrectly states contains 0.5mg estradiol whereas the bottle label correctly states contains 1.0mg estradiol |
| Jun 1, 2004 | Class II | D-261-4 | ESTRACE Tablets, (estradiol tablets, USP), 1mg, 100 tablets, Rx only, Mfd. by… Mislabeling: Outer carton incorrectly states contains 0.5mg estradiol whereas the bottle label correctly states contains 1.0mg estradiol |
| Aug 18, 2003 | Class II | D-037-4 | Estrace tablets (estradiol tablets, USP) 0.5mg, physician samples, 7 and 21 count boxes… and 2 more products Dissolution failure |
| Nov 14, 2002 | Class III | D-189-3 | Doryx Capsules (coated doxycycline hyclate pellets) 75mg, 6 blisterpack physician samples… Lack of assurance of stability throughout labeled expiration |
FDA record score
0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
5 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall D-822-2013, this FEI as the recalling firm | May 17, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall D-353-2008, this FEI as the recalling firm | Jun 23, 2008 | 10 years or older, so it adds no points | 0 |
| Class II recall D-067-5, this FEI as the recalling firm | Sep 8, 2004 | 10 years or older, so it adds no points | 0 |
| Class II recall D-261-4, this FEI as the recalling firm | Jun 1, 2004 | 10 years or older, so it adds no points | 0 |
| Class II recall D-037-4, this FEI as the recalling firm | Aug 18, 2003 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 17, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 17, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 17, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 17, 2026 | Newest record Nov 16, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Warner Chilcott US LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Warner Chilcott US LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Warner Chilcott US LLC
- Location
- Rockaway, NJ (US)
- Source
- inspections